Serum biomarkers like B12 or methylmalonic acid are not entirely useful in assessing or monitoring clinical improvement, and injection frequency should not be based on biomarker levels
Concerns may be higher with drugs that affect metabolism, blood sugar, sleep, or methyl-group pathways
A review of data on ivermectin for the management of tumors noted that studies showed more than a 50% reduction in tumor volumes with ivermectin treatment courses ranging from 10-42 days
Complementary peptides to try The BPC-157 peptide isnt the only amino acid chain that heals the gut
What is the quality of the evidencerandomized trials, observational studies, or anecdotal reports
Then theres other evidence such as where tablets have been introduced to treat patients with Pernicious Anaemia doctors still keep on prescribing the injections and anyway, patients are easily able to purchase injectable B12 from other sources and treat themselves